Lakeshore Biopharma Co. Ltd (LSBCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2021 | 03-2021 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 1,860 | 0 |
| TOTAL | $2,173 | $0 |
| Non-Current Assets | ||
| Investments And Advances | 200,001 | 0 |
| TOTAL | $200,001 | $N/A |
| Total Assets | $202,173 | $0 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 8 | 0 |
| Accrued Expenses | 776 | 0 |
| TOTAL | $783 | $0 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 196,390 | 0 |
| TOTAL | $196,390 | $N/A |
| Total Liabilities | $197,173 | $0 |
| Shareholders' Equity | ||
| Shares Outstanding, K | 2,575 | N/A |
| Common Shares | 1 | 0 |
| Retained earnings | -4,685 | 0 |
| TOTAL | $5,000 | $0 |
| Total Liabilities And Equity | $202,173 | $0 |